ESLA logo

Estrella Immunopharma, Inc.

ESLA
Healthcare|Biotechnology|US
$0.38
-0.03 (-8.49%)
DCF Value
$0.02
Cash / Share
$0.00

Ownership Breakdown

39.6%
Float
43.5M
Shares Outstanding
17.2M
Float Shares

Major Holders (2)

Combined: 10.0%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Armistice Capital, LLCIA, OO4.99%2,051,409Aug 14, 202613D/G
Steven BoydHC, IN4.99%2,051,409Aug 14, 202613D/G

Insider Trades (40)

Last 4 quarters: 1,302,100 acquired · 100,000 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Pussinen Cynthiadirector, officer: Chief Executive OfficerNov 2, 2026AWARD1,000,000$0.43$430.0KForm 4
Pussinen Cynthiadirector, officer: CEOOct 25, 2026OTHER0——Form 4
Liu Chengdirector, officer: CEOAug 25, 2026OPTION EX.100,000$0.81$81.5KForm 4
Liu Chengdirector, officer: CEOAug 25, 2026OPTION EX.100,000$0.81$81.5KForm 4
Xu JiandongChief Financial OfficerAug 18, 2026OPTION EX.100,000$0.81$81.5KForm 4
Xu JiandongChief Financial OfficerAug 18, 2026OPTION EX.100,000$0.81$81.5KForm 4
Xu JiandongChief Financial OfficerOct 7, 2025BUY1,000$1.33$1.3KForm 4
Xu JiandongChief Financial OfficerSep 11, 2025BUY100$1.04$104.00Form 4
Xu JiandongChief Financial OfficerSep 22, 2025BUY1,000$1.16$1.2KForm 4
Jia Dengyaodirector: Sep 22, 2025OTHER0——Form 4
Liu Chengdirector, officer: Chief Executive OfficerOct 30, 2024AWARD509,204$0.81$415.0KForm 4
Liu Chengdirector, officer: Chief Executive OfficerOct 30, 2024AWARD490,796$0.81$400.0KForm 4
Xu JiandongChief Financial OfficerOct 30, 2024AWARD509,204$0.81$415.0KForm 4
Xu JiandongChief Financial OfficerOct 30, 2024AWARD490,796$0.81$400.0KForm 4
Zhang Hongdirector, other: Chairperson of the BoardAug 14, 2024OTHER0——Form 4
Xu JiandongChief Financial OfficerSep 29, 2023DISPOSED0——Form 4
Roberts Marshadirector: Sep 29, 2023OTHER0——Form 4
Xu Peidirector: Sep 29, 2023OTHER0——Form 4
Liu Chengdirector, officer: Chief Executive OfficerSep 29, 2023DISPOSED0——Form 4
Wu Xuejun Janelledirector: Sep 29, 2023OTHER0——Form 4
Wu Fandirector: Sep 29, 2023OTHER0——Form 4
Eureka Therapeutics, Inc.10 percent ownerSep 29, 2023DISPOSED0——Form 4
Eureka Therapeutics, Inc.10 percent ownerSep 29, 2023OTHER0——Form 4
Owl Creek Asset Management, L.P.10 percent ownerSep 29, 2023DISPOSED255,000$10.86$2.8MForm 4
TradeUP Acquisition Sponsor LLCSep 29, 2023OTHER0——Form 4
Long JamesSep 29, 2023OTHER0——Form 4
Jiang TaoSep 29, 2023OTHER0——Form 4
Wen LuqiSep 29, 2023OTHER0——Form 4
Li JianweiSep 29, 2023OTHER0——Form 4
Twigg WestonSep 29, 2023OTHER0——Form 4
Yang WeiguangSep 29, 2023OTHER0——Form 4
Owl Creek Asset Management, L.P.directorJan 5, 2023OTHER0——Form 4
Li JianweiCo-Chief Executive OfficerMar 4, 2022BUY141,970$314700.00$44.68BForm 4
Jiang TaodirectorJul 14, 2021DISPOSED0——Form 4
Twigg WestondirectorJul 14, 2021DISPOSED0——Form 4
Long JamesdirectorJul 14, 2021DISPOSED0——Form 4
Yang Weiguangdirector, officer: Co-Chief Executive OfficerJul 14, 2021OTHER0——Form 4
TradeUP Acquisition Sponsor LLC10 percent ownerJul 14, 2021DISPOSED0——Form 4
Wen LuqiofficerJul 14, 2021OTHER0——Form 4
Li Jianweidirector, 10 percent owner, officer: Chairman and Co-CEOJul 14, 2021OTHER0——Form 4